TRCT
CPIX icon

Tower Research Capital (TRC)’s Cumberland Pharmaceuticals CPIX Stock Holding History

Tower Research Capital (TRC)’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-787
Closed -$2.46K – 5213
2025
Q3 		$2.46K Sell
787
-1,315
-63% -$4.37K ﹤0.01% 4626
2025
Q2 		$7.04K Buy
+2,102
New +$9.96K ﹤0.01% 4074
2025
Q1 		– Sell
-2,218
Closed -$5.26K – 5280
2024
Q4 		$5.26K Sell
2,218
-3,948
-64% -$5.82K ﹤0.01% 4324
2024
Q3 		$7.89K Sell
6,166
-442
-7% -$612 ﹤0.01% 4008
2024
Q2 		$10.1K Buy
6,608
+861
+15% +$1.35K ﹤0.01% 4178
2024
Q1 		$9.65K Buy
5,747
+119
+2% +$237 ﹤0.01% 3817
2023
Q4 		$10.1K Buy
5,628
+596
+12% +$1.09K ﹤0.01% 4295
2023
Q3 		$9.51K Sell
5,032
-2,231
-31% -$3.74K ﹤0.01% 4210
2023
Q2 		$10.7K Buy
7,263
+1,333
+22% +$2.3K ﹤0.01% 4083
2023
Q1 		$11K Buy
5,930
+2,463
+71% +$5.86K ﹤0.01% 4195
2022
Q4 		$8K Sell
3,467
-64
-2% -$148 ﹤0.01% 4373
2022
Q3 		$9K Sell
3,531
-1,367
-28% -$3.22K ﹤0.01% 4643
2022
Q2 		$10K Buy
4,898
+2,013
+70% +$4.66K ﹤0.01% 4436
2022
Q1 		$8K Sell
2,885
-3,294
-53% -$11K ﹤0.01% 4566
2021
Q4 		$29K Buy
6,179
+1,565
+34% +$5.33K ﹤0.01% 3253
2021
Q3 		$13K Buy
4,614
+3,834
+492% +$11.4K ﹤0.01% 4071
2021
Q2 		$2K Sell
780
-39
-5% -$115 ﹤0.01% 5024
2021
Q1 		$2K Sell
819
-3,842
-82% -$12.5K ﹤0.01% 5005
2020
Q4 		$13K Buy
4,661
+1,408
+43% +$4.26K ﹤0.01% 4136
2020
Q3 		$10K Buy
3,253
+1,578
+94% +$5.19K ﹤0.01% 4090
2020
Q2 		$6K Buy
1,675
+1,490
+805% +$5.42K ﹤0.01% 4205
2020
Q1 		$1K Buy
185
+77
+71% +$345 ﹤0.01% 2746
2019
Q4 		$1K Buy
+108
New +$570 ﹤0.01% 3233
2019
Q3 		– Sell
-2,596
Closed -$17K – 4137
2019
Q2 		$17K Buy
2,596
+2,259
+670% +$13.7K ﹤0.01% 2268
2019
Q1 		$2K Buy
337
+68
+25% +$394 ﹤0.01% 3387
2018
Q4 		$2K Sell
269
-3,922
-94% -$23.5K ﹤0.01% 3326
2018
Q3 		$24K Buy
4,191
+1,522
+57% +$8.97K ﹤0.01% 2213
2018
Q2 		$16K Buy
2,669
+2,238
+519% +$14K ﹤0.01% 2545
2018
Q1 		$3K Sell
431
-290
-40% -$2K ﹤0.01% 2849
2017
Q4 		$5K Buy
721
+287
+66% +$2.11K ﹤0.01% 2869
2017
Q3 		$3K Sell
434
-588
-58% -$4.07K ﹤0.01% 3462
2017
Q2 		$7K Buy
+1,022
New +$6.74K ﹤0.01% 1798
2017
Q1 		– Sell
-38
Closed – – 3164
2016
Q4 		$0 Sell
38
-1,276
-97% -$6.66K ﹤0.01% 3874
2016
Q3 		$7K Buy
1,314
+1,214
+1,214% +$5.71K ﹤0.01% 2307
2016
Q2 		$0 Sell
100
-1,649
-94% -$7.55K ﹤0.01% 4488
2016
Q1 		$8K Buy
1,749
+1,011
+137% +$4.82K ﹤0.01% 2176
2015
Q4 		$4K Buy
738
+723
+4,820% +$4.12K ﹤0.01% 3164
2015
Q3 		$0 Sell
15
-457
-97% -$2.85K ﹤0.01% 4096
2015
Q2 		$3K Buy
472
+235
+99% +$1.63K ﹤0.01% 3526
2015
Q1 		$1K Buy
237
+90
+61% +$562 ﹤0.01% 4030
2014
Q4 		$1K Buy
+147
New +$755 ﹤0.01% 3613
2014
Q2 		– Sell
-1,781
Closed -$8K – 4089
2014
Q1 		$8K Buy
+1,781
New +$8.47K ﹤0.01% 2805
2013
Q4 		– Sell
-1,688
Closed -$8K – 4515
2013
Q3 		$8K Buy
1,688
+1,071
+174% +$5.33K ﹤0.01% 3342
2013
Q2 		$3K Buy
+617
New +$3.07K ﹤0.01% 3266

Other funds holding CPIX

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Tower Research Capital (TRC)'s CPIX Position: Q4 2025 in Review

Tower Research Capital (TRC) sold out of Cumberland Pharmaceuticals (CPIX) in Q4 2025, closing a stake of 787 shares — an estimated $2.46K sold.

Tower Research Capital (TRC) first reported a position in CPIX in Q2 2013 and held it in 44 quarters. The position peaked at $29K in Q4 2021. 27 funds tracked by Wall St. Rank hold CPIX as of Q4 2025.

  • Tower Research Capital (TRC) reported no remaining Cumberland Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 787 Cumberland Pharmaceuticals shares in Q4 2025, an estimated $2.46K.
  • Tower Research Capital (TRC) first reported a position in Cumberland Pharmaceuticals in Q2 2013 and held it in 44 quarters.
  • Tower Research Capital (TRC)'s Cumberland Pharmaceuticals position peaked at $29K in Q4 2021.
  • 27 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q4 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2025, filed 17 Feb 2026.